Status:
COMPLETED
Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil
Lead Sponsor:
Novartis
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This extension study is considered to allow patients being treated with EC-MPS to collect further information on the long-term safety of this drug.
Eligibility Criteria
Inclusion
- Inclusion/ Exclusion criteria
- \- Only patients who were participating in study CERL080A2405-DE02 and have completed the first 6 months of the core study can be included in this additional extension study.
- Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT00238966
Start Date
November 1 2002
End Date
April 1 2005
Last Update
January 31 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.